Skip to main content

Together we are beating cancer

Donate now
  • For Supporters

Powering the future of lung cancer research 

by Scarlett O'Shea | Philanthropy and partnerships

19 November 2024

0 comments 0 comments

Scientist in the lab
ScottishPower x CRUK

We’re delighted that our long-standing partner ScottishPower, who have raised £40m since our partnership began in 2012, will continue to partner with us for the next 5 years.

While continuing to support all aspects of our work, they will specifically support the Cancer Research UK Lung Cancer Centre of Excellence (LCCE).  The green renewable energy company has confirmed it is aiming to raise a further £10million by 2029 with up to £4m of this supporting the LCCE.   

This commitment is a continuation of ScottishPower’s support for our efforts to tackle lung cancer after they supported the TOPICAL study- a project which helped our scientists better understand the link between air pollution and lung cancer in people who have never smoked.   Their support of the Lung Cancer Centre of Excellence is an exciting opportunity to support advances in the prevention, diagnosis and treatment of the disease, with an ultimate goal to improve outcomes for people with lung cancer.  

Announcing this latest funding commitment, Andrew Ward, CEO of ScottishPower’s Customer Business said:   

“I’m incredibly proud of what we’ve achieved for Cancer Research UK through our long-standing partnership. We started this journey with them in 2012 with the aim of raising £5million in three years and to have had our incredible employees, suppliers and customers go on since then to raise £40million for life-saving research is nothing short of phenomenal. 

“We’re determined we’re not stopping now. Cancer affects all of us, whether personally or through someone we know and care for. Lung cancer is one of the UK’s biggest killers and our support of TOPICAL has already helped researchers better understand the link between lung cancer and air pollution so it’s incredibly important to me that this money will go to where it’s really needed – helping with research to ultimately help more people live longer better lives, free from the fear of cancer..”  

Commenting on the partnership renewal and support for the LCCE, Michelle Mitchell, CEO of Cancer Research UK said:  

“We’re thrilled ScottishPower will support the CRUK Lung Cancer Centre of Excellence and the broad work of the charity. It’s a privilege to have them as one of our longest standing corporate partners.  We’re incredibly proud of what our work together has achieved over the last 12 years, and we have big ambitions for what it will achieve in the future.

In the past decade,  the Cancer Research UK Lung Cancer Centre of Excellence has united world-leading researchers, advancing treatment for this hard-to-treat cancer. With ScottishPower’s support over the next five years,  we can sustain momentum and enhance research infrastructure to discover new methods for preventing, detecting and treating lung cancer.”

Since 2012 ScottishPower has raised money through initiatives including its Help Beat Cancer energy tariff, employee and customer fundraising, as well as sponsorship of Race for Life events across the UK and Stand Up To Cancer campaigns. Every penny raised through these initiatives contributes towards Cancer Research UK’s pioneering work which is saving lives in the UK and around the world. 

Thank you ScottishPower. We can’t wait to see what the next 5 years of our partnership will bring.  

With the incredible ambition of reaching £50m by 2029 including their support of the Lung Cancer Centre of Excellence, ScottishPower are clearly demonstrating they have the energy to help beat cancer and help us achieve our vision to bring about a world where everybody can live longer, better lives, free from the fear of cancer. 

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.